BIOLASE Announces Participation At The Sidoti & Company Fall 2018 Investor Conference In New York City September 27, 2018

Loading...
Loading...

BIOLASE Announces Participation At The Sidoti & Company Fall 2018 Investor Conference In New York City September 27, 2018

PR Newswire

IRVINE, Calif., Sept. 19, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ CM:BIOL), the global leader in dental lasers, today announced John Beaver, Executive Vice President and Chief Financial Officer, is scheduled to present at the Sidoti & Company Fall 2018 Investor Conference at 10:55 am Eastern Time on Thursday, September 27.  He is also scheduled to participate in one-on-one meetings with investors during the Conference. The conference is being held at the Grand Hyatt in New York City.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

A live webcast and a 90-day replay of the presentation will be available on the BIOLASE Investor Events Page.

Mr. Beaver will also be available to participate in one-on-one meetings with investors in New York City on Wednesday, September 26.  To arrange a meeting, please contact Nathan Abler by e-mail at nabler@dresnerallencaron.com or by phone at (714) 742-4180.

About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times.  BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients.  BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-announces-participation-at-the-sidoti--company-fall-2018-investor-conference-in-new-york-city-september-27-2018-300715209.html

SOURCE BIOLASE, Inc.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releasestrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...